Crosscheck

Your medical. Crosschecked.

Cetirizine

Other names: Zyrtec, Zerviate

The FAA's guidance for cetirizine depends on how it is taken. Each way is below, with its own FAA source and date.

By mouth (Zyrtec)

FAA guidance

Acceptable with conditions.

Wait

Initial observation time of 48 hours, as noted in the allergy sheet's table, or 5 times the half-life or maximal dosing interval after the last dose

A general FAA rule gives a different wait. The specific one applies.

Examiner

The examiner can issue when the document's criteria are met

FAA label

CONDITIONALLY ACCEPTABLE

Source: FAA, Allergy – Antihistamines & Immunotherapy Medication. FAA date 30 September 2026. Checked by Crosscheck 14 October 2026

The FAA's allergy sheet lists oral cetirizine (Zyrtec) as conditionally acceptable; it may be used occasionally (1-2 times a week) if other certification criteria are met, with the stipulation that the pilot not exercise the privileges of the airman certificate while taking it, and daily use is not acceptable.

Track your medications
Compare FAA documents: cetirizineWhat each of the two FAA documents says, in plain wordsOpen

The FAA's documents differ. The allergy sheet lists cetirizine and levocetirizine as conditionally acceptable with a 48-hour initial observation; the general over-the-counter guide lists both as No Go with a five-dosage-interval wait.

Its table gives an initial observation time of 48 hours; the sheet says an initial observation time is required to mitigate central nervous system risk, either as noted in the table or 5 times the half-life or maximal dosing interval after the last dose. The allergy sheet also says airmen who are exhibiting symptoms, regardless of the treatment used, must not fly.

The FAA's over-the-counter guide lists cetirizine (Zyrtec) among its sedating products to avoid, as "No Go", and says to wait at least five dosage intervals after the last dose before flying if the pilot takes any of its No Go medications.

Show the FAA's words: cetirizineThe official FAA wording: four passages, each with its document and dateOpen
FAA, Allergy – Antihistamines & Immunotherapy Medication · FAA date 30 September 2026
CONDITIONALLY ACCEPTABLE (Sedating) Antihistamine Medications
May be used occasionally (1-2 x per week) as a single agent or in any combination product if other certification criteria are met. NOT FOR DAILY USE.
Medication Drug Class Initial observation
Oral: Some Second-Generation Histamine-H1 receptor antagonist
cetirizine (Zyrtec)
levocetirizine (Xyzal)
48 hours
48 hours
FAA, Allergy – Antihistamines & Immunotherapy Medication · FAA date 30 September 2026
Airmen who are exhibiting symptoms, regardless of the treatment used, must not fly.
FAA, Allergy – Antihistamines & Immunotherapy Medication · FAA date 30 September 2026
Conditionally acceptable medications:
May be used occasionally (1-2 times a week) with the stipulation that the airman not exercise the privileges of airman certificate while taking the medication.
Daily use is NOT acceptable.
Initial observation time: Required to mitigate central nervous system risk, either as noted in the table below or 5x the half-life or maximal dosing interval after the last dose.
FAA, What Over-the-Counter (OTC) Medications Can I Take and Still Be Safe to Fly? · FAA date 28 August 2024
4. NO GO Medications:
If you take any of the NO GO medications listed in the OTC Medications Reference Table OR if you have previously had side effects from the medication, wait at least five (5) dosage intervals after the last dose before flying.
AVOID
These can cause incapacitation.
NO GO
Sedating products:
brompheniramine (Dimetapp)
cetirizine (Zyrtec)
chlorpheniramine (Chlor- Trimeton)
diphenhydramine (Benadryl)
levocetirizine Xyzal)
dimenhydrinate (Dramamine)
meclizine (Antivert)
Sedating antihistamines can cause drowsiness and impaired thinking and judgement.
NOTE: Sedating antihistamines are commonly found in autopsy after aircraft accidents. The wait times for these medications are longer than noted in the “Dosage Interval Wait Timetable” due to their longer half-life. Consult your AME.
Sources and dates: cetirizineTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

Eye drops (Zerviate)

cetirizine (ophthalmic)

FAA guidance

Acceptable with conditions.

Wait

48 hours

after the first dose

There is more to this wait.

Source: FAA, MedGuide (FAA Office of Aerospace Medicine medication reference). FAA date 1 October 2026. Checked by Crosscheck 14 October 2026

The FAA's MedGuide lists cetirizine (ophthalmic) (Zerviate) as allowed, for allergic conjunctivitis, with a wait of 48 hours after the first dose; after each dose, no flying or safety-related duties while experiencing blurry vision or pain; and none after the final dose, used per label directions.

More detail: cetirizine (ophthalmic)The rest of Crosscheck's reading, in plain wordsOpen

Wait

  • after each dose, no flying or safety-related duties while experiencing blurry vision or pain

The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.

  • 48 hours after the first dose: ground observation
Show the FAA's words: cetirizine (ophthalmic)The official FAA wording: three passages, each with its document and dateOpen
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Generic: cetirizine (ophthalmic)
Brand Name: Zerviate
Drug Class: Antihistamine (H1) Second Generation
Underlying Condition: Allergic conjunctivitis
Use: ALLOW
INITIAL Wait Time (after first dose): 48 hours
SUBSEQUENT Dose Wait Time (after each dose): Do not fly or perform SRD while experiencing blurry vision or pain.
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.
Sources and dates: cetirizine (ophthalmic)One FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.